The primary endpoint is the ratio of Th1 (intracellular IFN-gamma plus) versus Th2 (intracellular IL-4 plus) T-cells in the apheresis products collected from individual donors undergoing G-CSF and AMD3100 hematopoietic progenitor cell mobilization.